Teleflex Inc. (NYSE:TFX) hit a new 52-week high on Friday . The stock traded as high as $181.62 and last traded at $181.27, with a volume of 85,336 shares traded. The stock had previously closed at $179.14.

Several equities research analysts have recently weighed in on TFX shares. Barclays PLC reaffirmed an “overweight” rating and issued a $183.00 target price (up previously from $170.00) on shares of Teleflex in a research report on Tuesday, June 14th. Zacks Investment Research raised Teleflex from a “hold” rating to a “buy” rating and set a $175.00 target price for the company in a research report on Wednesday, April 20th. Deutsche Bank AG reaffirmed a “buy” rating on shares of Teleflex in a research report on Monday, March 14th. Brean Capital reaffirmed a “buy” rating and issued a $157.00 target price (up previously from $149.00) on shares of Teleflex in a research report on Friday, March 11th. Finally, Leerink Swann upped their target price on Teleflex from $153.00 to $171.00 and gave the stock a “market perform” rating in a research report on Monday, May 2nd. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $165.11.

The firm has a 50 day moving average price of $169.54 and a 200 day moving average price of $151.23. The company has a market cap of $7.93 billion and a price-to-earnings ratio of 34.23.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, April 28th. The medical technology company reported $1.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.35 by $0.17. The company had revenue of $424.90 million for the quarter, compared to the consensus estimate of $425.37 million. During the same quarter last year, the business earned $1.30 earnings per share. Teleflex’s quarterly revenue was down 1.0% on a year-over-year basis. On average, equities analysts predict that Teleflex Inc. will post $7.24 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 15th. Shareholders of record on Monday, May 16th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, May 12th. This represents a $1.36 annualized dividend and a yield of 0.76%.

In other Teleflex news, Director Stuart A. Randle sold 797 shares of the firm’s stock in a transaction dated Monday, June 6th. The stock was sold at an average price of $166.10, for a total transaction of $132,381.70. Following the transaction, the director now directly owns 4,592 shares in the company, valued at $762,731.20. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Thomas Anthony Kennedy sold 15,102 shares of the firm’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $160.20, for a total value of $2,419,340.40. Following the transaction, the vice president now owns 6,990 shares in the company, valued at $1,119,798. The disclosure for this sale can be found here.

Several large investors have modified their holdings of the stock. Mastrapasqua Asset Management Inc. increased its stake in shares of Teleflex by 9.8% in the fourth quarter. Mastrapasqua Asset Management Inc. now owns 10,305 shares of the medical technology company’s stock valued at $1,355,000 after buying an additional 920 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Teleflex by 0.4% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,062 shares of the medical technology company’s stock worth $1,586,000 after buying an additional 53 shares during the period. GSA Capital Partners LLP increased its stake in Teleflex by 65.2% in the fourth quarter. GSA Capital Partners LLP now owns 16,811 shares of the medical technology company’s stock worth $2,210,000 after buying an additional 6,634 shares during the period. Eagle Asset Management Inc. purchased a new stake in Teleflex during the fourth quarter worth $3,183,000. Finally, Twin Capital Management Inc. increased its stake in Teleflex by 29.2% in the fourth quarter. Twin Capital Management Inc. now owns 26,540 shares of the medical technology company’s stock worth $3,489,000 after buying an additional 6,000 shares during the period.

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company also markets and sells its products to hospitals and healthcare providers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.